Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2011, Article ID 803429, 6 pages
http://dx.doi.org/10.1155/2011/803429
Research Article

The Interleukin-6 Gene Promoter Polymorphism -174 and Atherosclerotic Events in Overweight Transplanted Patients

Jamal Bamoulid,1,2,3,4 Cécile Courivaud,1,2,3,4 Marina Deschamps,1,2,3,5 Béatrice Gaugler,1,2,3,5 Pierre Tiberghien,1,2,3,5,6 Jean-Marc Chalopin,1,2,3,4,6 Philippe Saas,1,2,3,5,6 and Didier Ducloux1,2,3,4,6

1INSERM, UMR645, 25020 Besançon, France
2Université de Franche-Comté, Faculté de Médecine et de Pharmacie, 25020 Besançon, France
3Institut Fédérative de Recherche, IFR133, 25000 Besançon, France
4CHU Saint Jacques, Department of Nephrology, Dialysis, and Renal Transplantation, 25030 Besançon, France
5EFS Bourgogne Franche-Comté, Plateforme de Biomonitoring, CIC-BT506, 25020 Besançon, France
6CHU Saint Jacques, CIC Biothérapie, CIC-BT 506, 25030 Besançon, France

Received 26 October 2010; Revised 1 February 2011; Accepted 14 March 2011

Academic Editor: Eric Thervet

Copyright © 2011 Jamal Bamoulid et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. M. Ridker, M. Cushman, M. J. Stampfer, R. P. Tracy, and C. H. Hennekens, “Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men,” The New England Journal of Medicine, vol. 336, no. 14, pp. 973–979, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Ducloux, A. Kazory, and J. M. Chalopin, “Predicting coronary heart disease in renal transplant recipients: a prospective study,” Kidney International, vol. 66, no. 1, pp. 441–447, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. D. Pradhan, J. E. Manson, N. Rifai, J. E. Buring, and P. M. Ridker, “C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus,” Journal of the American Medical Association, vol. 286, no. 3, pp. 327–334, 2001. View at Google Scholar · View at Scopus
  4. J. Bamoulid, C. Courivaud, M. Deschamps et al., “IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation,” Journal of the American Society of Nephrology, vol. 17, no. 8, pp. 2333–2340, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Fantuzzi, “Adipose tissue, adipokines, and inflammation,” Journal of Allergy and Clinical Immunology, vol. 115, no. 5, pp. 911–920, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, p. 1215, 1988. View at Google Scholar · View at Scopus
  7. D. Ducloux, B. Challier, P. Saas, P. Tiberghien, and J. M. Chalopin, “CD4 cell lymphopenia and atherosclerosis in renal transplant recipients,” Journal of the American Society of Nephrology, vol. 14, no. 3, pp. 767–772, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Fishman, G. Faulds, R. Jeffey et al., “The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic- onset juvenile chronic arthritis,” Journal of Clinical Investigation, vol. 102, no. 7, pp. 1369–1376, 1998. View at Google Scholar · View at Scopus
  9. P. C. Heinrich, J. V. Castell, and T. Andus, “Interleukin-6 and the acute phase response,” Biochemical Journal, vol. 265, no. 3, pp. 621–636, 1990. View at Google Scholar
  10. “Freely associating,” Nature Genetics, vol. 22, pp. 1–2, 1999.
  11. A. Riikola, K. Sipilä, M. Kähönen et al., “Interleukin-6 promoter polymorphism and cardiovascular risk factors: The Health 2000 Survey,” Atherosclerosis, vol. 207, no. 2, pp. 466–470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. F. C. McGillicuddy, M. L. De La Moya, C. C. Hinkle et al., “Inflammation impairs reverse cholesterol transport in vivo,” Circulation, vol. 119, no. 8, pp. 1135–1145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. B. L. Wajchenberg, M. Nery, M. R. Cunha, and M. E. R. da Silva, “Adipose tissue at the crossroads in the development of the metabolic syndrome, inflammation and atherosclerosis,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 53, no. 2, pp. 145–150, 2009. View at Google Scholar · View at Scopus
  14. G. R. Hajer, T. W. Van Haeften, and F. L. J. Visseren, “Adipose tissue dysfunction in obesity, diabetes, and vascular diseases,” European Heart Journal, vol. 29, no. 24, pp. 2959–2971, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Khoury, J. Little, M. Gwinn, and J. P. A. Ioannidis, “On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies,” International Journal of Epidemiology, vol. 36, no. 2, pp. 439–445, 2007. View at Publisher · View at Google Scholar · View at Scopus